Q&A: Owkin’s five-year Sanofi deal bets on ‘purpose-built’ AI agents
Image from Owkin Over the past two years, software engineering has handed a growing share of its routine…
Sanofi and Owkin partner to develop next-generation biopharma AI agents
Sanofi has entered a multi-year agreement with France-based agentic AI company Owkin to co-develop next-generation AI-driven biopharma agents.…
Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agents
A 3D rendering of a biological cell from the company’s homepage, where it animates to reveal layers of…
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
K Pro, Owkin’s AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. NEW…